Haemonetics Corp (HAE)

EBITDA Margin

22.01%

Quarterly · Period ending:

HAE logo

HAE EBITDA Margin

Latest reported22.01%
HAE Quarterly EBITDA Margin (100.00% → 22.01%)
High-resolution chart · PNG

HAE ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Haemonetics Corp EBITDA Margin — Quarterly
Period endingEBITDA Margin
22.0063%
1.2398%
28.1685%
26.5041%
29.153%
29.929%
27.2954%
25.7529%
23.8313%
22.442%
24.5422%
20.6281%
24.6297%
23.0313%
21.9105%
23.7091%
20.336%
22.107%
23.074%
20.3166%
8.8567%
24.2898%
24.9581%
22.9562%
17.1308%
30.3117%
27.2059%
27.7278%
26.7665%
21.5155%
22.7466%
21.2571%
13.8253%
15.9515%
9.9529%
20.6121%
22.0426%
10.2115%
19.0879%
21.5675%
6.9838%
13.5292%
17.8658%
19.0821%
12.1178%
5.0945%
7.8766%
5.4517%
8.3947%
14.6513%
7.3765%
9.9383%
5.3516%
16.2818%
13.6939%
4.538%
7.4112%
18.4336%
13.247%
10.3463%
14.0166%
23.289%
16.1543%
17.3257%
22.6559%
9.0849%
22.2239%
23.5347%
23.4978%
15.9144%
22.6875%
16.1795%
13.4156%
20.9718%
14.5608%
12.0615%
12.9404%
27.3232%
14.9788%
19.983%
19.8213%
51.4996%
39.087%
15.3043%
17.9262%
22.6287%
22.1156%
23.1823%
23.3853%
22.1518%
23.8976%
19.605%
17.8641%
15.3336%
22.6574%
19.5519%
20.4504%
34.845%
7.7537%
28.0085%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.